Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity.
Zhuoyue LiJingru WangJunwei LiuJianming YuJingwen WangHui WangQingchao WeiMan LiuMeiqi XuZhenhan FengTing ZhongXuan ZhangPublished in: Journal of functional biomaterials (2024)
Multifunctional nanoparticles are of significant importance for synergistic multimodal antitumor activity. Herein, zinc oxide (ZnO) was used as pH-sensitive nanoparticles for loading the chemotherapy agent doxorubicin (DOX) and the photosensitizer agent indocyanine green (ICG), and biocompatible low-molecular-weight heparin (LMHP) was used as the gatekeepers for synergistic photothermal therapy/photodynamic therapy/chemotherapy/immunotherapy. ZnO was decomposed into cytotoxic Zn 2+ ions, leading to a tumor-specific release of ICG and DOX. ZnO simultaneously produced oxygen (O 2 ) and reactive oxygen species (ROS) for photodynamic therapy (PDT). The released ICG under laser irradiation produced ROS for PDT and raised the tumor temperature for photothermal therapy (PTT). The released DOX directly caused tumor cell death for chemotherapy. Both DOX and ICG also induced immunogenic cell death (ICD) for immunotherapy. The in vivo and in vitro results presented a superior inhibition of tumor progression, metastasis and recurrence. Therefore, this study could provide an efficient approach for designing multifunctional nanoparticles for synergistic multimodal antitumor therapy.
Keyphrases
- photodynamic therapy
- fluorescence imaging
- cell death
- cancer therapy
- reactive oxygen species
- drug delivery
- quantum dots
- room temperature
- locally advanced
- pain management
- reduced graphene oxide
- cell cycle arrest
- dna damage
- visible light
- stem cells
- ionic liquid
- rectal cancer
- venous thromboembolism
- poor prognosis
- diabetic rats
- mesenchymal stem cells
- metal organic framework
- endothelial cells
- high glucose
- signaling pathway
- chemotherapy induced
- mass spectrometry
- free survival
- cell proliferation
- anti inflammatory
- pi k akt
- replacement therapy